Platelet-rich plasma (PRP) · Lesson 11 of 25 · 3 min

PRP for tendon, ligament and muscle injuries: what the research shows

PRP research in sports medicine differs by tissue and condition. Tennis elbow has the most data, while Achilles, ACL and muscle injury findings are mixed.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • PRP has been studied as an option between conservative care and surgery, with evidence that varies by condition.
  • In tennis elbow, reviews report corticosteroids ahead at 1 month and PRP ahead at 6 months.
  • Achilles tendinopathy evidence is heterogeneous, and several reviews have not shown clear benefit.
  • PRP added to ACL reconstruction has not been shown to improve long-term stability or graft healing.
  • Trials in acute muscle strains have not shown a faster return to play.
  • PRP is studied alongside rehabilitation, not as a replacement for it.

Why PRP is studied in tendons

Tendinopathy is a chronic tendon disorder marked by pain and structural change. The tissue shows disorganized collagen, new vessel growth and altered tendon cell behavior.

Platelet-rich plasma (PRP) delivers concentrated growth factors from the patient's own platelets. Researchers have tested whether this changes the course of tendon disease. Results depend on the tendon involved, the preparation used and the rehabilitation that follows.

Tendon findings by site

Lateral epicondylitis (tennis elbow) is the most studied site. A 2023 meta-analysis of level 1 and 2 studies reported that corticosteroid injections were superior at 1 month, while PRP was more effective at 6 months. This time pattern is a recurring theme in tendon research.

Achilles tendinopathy is less clear. Systematic reviews describe a heterogeneous evidence base, and outcomes appear to differ between insertional and non-insertional disease. Rotator cuff research has focused on tendinopathy, partial tears and surgical augmentation.

Ligament and muscle injuries

Ligaments have a poor blood supply and limited capacity to heal. A 2022 systematic review of 14 randomized trials looked at PRP used with ACL reconstruction. It suggested possible short-term gains in pain and early function, but no improvement in long-term stability, tunnel widening or graft incorporation.

For acute lateral ankle sprains, a 2024 critical appraisal found moderate support for reduced pain and better function. For acute muscle strains, results are mixed, and randomized trials have not shown faster return to play or fewer reinjuries than standard rehabilitation.

Rehabilitation and regulatory status

The course material treats PRP as a biological addition to mechanical loading, not a standalone treatment. Both complete rest and excessive early loading are described as potential problems after injection.

PRP applications are considered off-label. Patients should be told where the evidence for their specific condition is strong, mixed or lacking.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Condition-by-condition review of the trial data
  • Injection approach and guidance for each tendon and ligament
  • Choosing a PRP formulation for a given tissue
  • Post-injection loading and return-to-activity planning
  • Setting patient expectations on timing of response

Common questions.

Is PRP better than a cortisone injection for tennis elbow?
Published meta-analyses report a time pattern. Corticosteroids gave better relief at 1 month, and PRP showed better outcomes at 6 months.
Does PRP speed recovery from a hamstring strain?
The evidence is mixed. Randomized trials have not shown faster return to play or lower reinjury rates compared with standard rehabilitation, so this use is regarded as experimental.
Does adding PRP improve ACL reconstruction results?
A 2022 systematic review of 14 randomized trials suggested possible short-term benefits in pain and function. It did not find improvement in long-term stability or graft incorporation.

Sources

  • Andriolo L, et al. (2019). Nonsurgical treatments of patellar tendinopathy: multiple injections of platelet-rich plasma are a suitable option: a systematic review and meta-analysis. Am J Sports Med, 47(4):1001-1018.
  • Fitzpatrick J, et al. (2017). The effectiveness of platelet-rich plasma in the treatment of tendinopathy: a meta-analysis of randomized controlled clinical trials. Am J Sports Med, 45(1):226-233.
  • Maffulli N, et al. (2020). The pathophysiology of tendinopathy. Sports Med Arthrosc Rev, 28(4):131-137.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.